MENU
+Compare
HSDT
Stock ticker: NASDAQ
AS OF
Jan 24 closing price
Price
$0.69
Change
-$0.09 (-11.54%)
Capitalization
5.17M

HSDT Helius Medical Technologies Forecast, Technical & Fundamental Analysis

a medical technology company focused on neurological wellness

HSDT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for HSDT with price predictions
Jan 24, 2025

HSDT's Stochastic Oscillator is remaining in oversold zone for 1 day

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 15, 2025. You may want to consider a long position or call options on HSDT as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

HSDT moved above its 50-day moving average on December 20, 2024 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HSDT advanced for three days, in of 220 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 89 cases where HSDT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for HSDT moved out of overbought territory on January 22, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 15 similar instances where the indicator moved out of overbought territory. In of the 15 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for HSDT turned negative on January 24, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HSDT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

HSDT broke above its upper Bollinger Band on January 21, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.650) is normal, around the industry mean (23.424). P/E Ratio (0.145) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (4.062) is also within normal values, averaging (41.167).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. HSDT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HSDT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
HSDT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

HSDT is expected to report earnings to rise 9,616.67% to -582 cents per share on November 15

Helius Medical Technologies HSDT Stock Earnings Reports
Q3'23
Est.
$-5.83
Q2'23
Beat
by $0.06
Q1'23
Beat
by $0.05
Q4'22
Missed
by $0.04
Q3'22
Beat
by $0.09
The last earnings report on August 10 showed earnings per share of -5 cents, beating the estimate of -11 cents. With 672.71K shares outstanding, the current market capitalization sits at 5.17M.
A.I. Advisor
published General Information

General Information

a medical technology company focused on neurological wellness

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
642 Newtown Yardley Road
Phone
+1 215 944-6100
Employees
26
Web
https://www.heliusmedical.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVCT6.550.13
+2.02%
Nuvectis Pharma
NPKI7.670.05
+0.66%
NPK International Inc
CYBR359.720.79
+0.22%
CyberArk Software Ltd
GLMD2.93-0.01
-0.32%
Galmed Pharmaceuticals Ltd
INTA69.20-2.02
-2.84%
Intapp

HSDT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HSDT has been loosely correlated with STSS. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if HSDT jumps, then STSS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HSDT
1D Price
Change %
HSDT100%
-12.18%
STSS - HSDT
36%
Loosely correlated
-5.17%
HSCS - HSDT
32%
Poorly correlated
-2.46%
A - HSDT
24%
Poorly correlated
-0.66%
STE - HSDT
24%
Poorly correlated
-0.09%
SHC - HSDT
23%
Poorly correlated
-0.29%
More